Clinical Trials Browser

Phase 2 × INDUSTRY × sonidegib × Clear all

NCT01327053 2019-08-28

BOLT

Phase 2 Completed

230 enrolled 26 charts

Carcinoma, Basal Cell, Skin Neoplasms

NCT01708174 2017-08-11

A Phase II Study of Oral LDE225 in Patients With Hedge-Hog (Hh)-Pathway Activated Relapsed Medulloblastoma (MB)

Phase 2 Completed

22 enrolled 12 charts

Medulloblastoma, Recurrence

NCT01826214 2016-08-30

Study of Efficacy and Safety of LDE225 in Adult Patients With Relapsed/Refractory Acute Leukemia

Phase 2 Completed

70 enrolled 12 charts

LymphoidOther hematologic neoplasm

Leukemia, Recurrence, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02002689 2016-05-02

SIGNATURE

Phase 2 Terminated

10 enrolled 9 charts

DermatologicGastrointestinalGynecologicOther hematologic neoplasm

Basal Cell Nevus Syndrome, Colonic Neoplasms, Endometrial Neoplasms, Hematologic Neoplasms

NCT01350115 2015-10-19

Efficacy, Safety and Pharmacokinetics of Oral LDE225 in Treatment of Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS)

Phase 2 Completed

10 enrolled 9 charts

Basal Cell Nevus Syndrome, Carcinoma, Basal Cell